Back to Search
Start Over
Formulary decision-makers update P&T policies following COX-2 inhibitor withdrawals
- Source :
- Formulary. July 2005, Vol. 40 Issue 7, 214
- Publication Year :
- 2005
-
Abstract
- Following the voluntary withdrawal of rofecoxib in September 2004 and the subsequent FDA-requested withdrawal of valdecoxib in April 2005, formulary decision-makers are considering options in navigating the changing pain management [...]
- Subjects :
- Product defects and recalls
Marketing
Laws, regulations and rules
Government regulation
Company marketing practices
COX-2 inhibitors -- Product defects and recalls -- Marketing -- Laws, regulations and rules
Medical formularies -- Laws, regulations and rules
Pain management -- Laws, regulations and rules
Pain -- Care and treatment
Medicine -- Formulae, receipts, prescriptions
Subjects
Details
- Language :
- English
- ISSN :
- 1082801X
- Volume :
- 40
- Issue :
- 7
- Database :
- Gale General OneFile
- Journal :
- Formulary
- Publication Type :
- Periodical
- Accession number :
- edsgcl.135648101